TEM
Tempus AI, Inc. Class A Common StockNASDAQ
Healthcare • Health Information Services
Factor tilt: Large-Cap Blend
$76.05+7.98%
Close Nov 6, 2026
- Market cap
- $13.79B
- 1 month
- +9.8%
- 3 months
- +38.1%
- 1 year
- -7.5%
- 52-week range
- $41.55$85.08
- Dividend
- No dividends on record
- Short interest
- 21.8% of float25.4M shares · settled Oct 15, 2026 · +1.0% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Sep 30, 2026
- Revenue
- $1.51B
- Net income
- -$189.29M
- Free cash flow
- -$66.79M
- Book value
- $500.4M
- Total debt
- $1.26B
- P/E
- —
- Price / sales
- 9.1×
- Price / book
- 27.6×
- FCF yield
- -0.5%
- Net margin
- -12.5%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Tempus AI, Inc. Class A Common Stock
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as
Read more
an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
- Website
- tempus.com
- Headquarters
- Chicago, IL, United States
- Employees
- 3,800
- Listed
- Jun 14, 2024
- Fiscal year ends
- December
Company profile from EODHD, stored Nov 4, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Nov 2, 2026 | $411.5M | +23.1% | 72.3% | -$56.9M | -$14.9M |
| Jun 2026filed Jul 30, 2026 | $382.5M | +21.6% | 64.4% | -$75.9M | $5.6M |
| Mar 2026filed May 5, 2026 | $348.1M | +36.1% | 63.8% | -$84.7M | -$125.9M |
| Dec 2025filed Feb 24, 2026 | $367.2M | +83.0% | 64.7% | -$61.4M | -$54.2M |
| Sep 2025filed Nov 4, 2025 | $334.2M | +84.7% | 62.8% | -$61.0M | -$80.0M |
| Jun 2025filed Aug 8, 2025 | $314.6M | +89.6% | 62.0% | -$61.8M | -$42.8M |
| Mar 2025filed May 6, 2025 | $255.7M | +75.4% | 60.7% | -$68.7M | -$68.0M |
| Dec 2024filed Feb 24, 2025 | $200.7M | +35.8% | 60.8% | -$50.7M | -$13.0M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 24, 2026 | $1.3B | +83.4% | 62.7% | -$252.9M | -$245.0M |
| Dec 2024filed Feb 24, 2025 | $693.4M | +30.4% | 55.0% | -$691.1M | -$705.8M |
| Dec 2023filed Dec 31, 2023 | $531.8M | +65.8% | 53.8% | -$196.1M | -$214.1M |
| Dec 2022filed Dec 31, 2022 | $320.7M | +24.4% | 40.6% | -$265.4M | -$289.8M |
| Dec 2021filed Dec 31, 2021 | $257.9M | +37.2% | 32.4% | -$243.7M | -$259.2M |
| Dec 2020filed Dec 31, 2020 | $188.0M | +203.0% | 15.3% | -$193.5M | -$209.9M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched TEM. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
25,375,199 shares short
+256,493 shares (+1%) vs Sep 30, 2026
21.8% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
25,118,706 shares short
-2,940,644 shares (-10.5%) vs Sep 15, 2026
21.6% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
28,059,350 shares short
-1,404,946 shares (-4.8%) vs Aug 31, 2026
24.6% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
29,464,296 shares short
-407,536 shares (-1.4%) vs Aug 14, 2026
25.9% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
29,871,832 shares short
-3,357,333 shares (-10.1%) vs Jul 31, 2026
26.2% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
33,229,165 shares short
+2,869,081 shares (+9.5%) vs Jul 15, 2026
29.2% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind TEM’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
No qualified split events are stored. This does not establish that the stock has never split.
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if TEM is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
63 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Oct 30, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 3 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 4
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
490 filers reported a long position in TEM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
53.1%
of the 110.6M shares 13-F filers reported
Moves vs Q1 2026
5 added4 trimmed
1 unchanged
Net shares held
+2.9%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | ARK Investment Management LLC | $580.6M · 10M shares | 10M | +4.3% |
| 2 | BlackRock, Inc. | $480.3M · 8.3M shares | 8.3M | -7.6% |
| 3 | BAILLIE GIFFORD & CO | $474.5M · 8.2M shares | 8.2M | -5.3% |
| 4 | SOFTBANK GROUP CORP. | $313.1M · 5.4M shares | 5.4M | Unchanged |
| 5 | JPMORGAN CHASE & CO | $291.2M · 5M shares | 5M | +1.1% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $289M · 5M shares | 5M | +1.4% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | $284.7M · 4.9M shares | 4.9M | +5% |
| 8 | Sumitomo Mitsui Trust Group, Inc. | $236.9M · 4.1M shares | 4.1M | -5.5% |
| 9 | Amova Asset Management Americas, Inc. | $236.6M · 4.1M shares | 4.1M | -5.5% |
| 10 | GOLDMAN SACHS GROUP INC | $217.9M · 3.8M shares | 3.8M | +194.4% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of TEM file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Nov 6, 2026 | ARK Investment Management LLC13G · passive · amended | 4.91%under 5% |
| May 7, 2026 | BAILLIE GIFFORD & CO13G · passive · amended | 5% |
| Mar 27, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Get the Full Analysis for TEM
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.